ClinicalTrials.gov
public full text
Public Domain
28 Day Repeat Dose in Cystic Fibrosis Patients
The purpose of this study is to determine whether the safety, tolerability and pharmacodynamics of SB656933 in patients that have cystic fibrosis
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Feasibility and Tolerance of High-Intensity Interval Training in Adults With Cystic Fibrosis#424880
- A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis#811301
- Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)#887576
- Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough#883040
- Use of Personal Fitness Device in Adult (> 21 Years Old) Patients With Cystic Fibrosis#1058817
Record · ID 806235
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive